Overexpression of Aryl Hydrocarbon Receptor in Human Lung Carcinomas

Toxicologic Pathology

Volumn 31, Issue 1, 2003, Pages 22-30

  Pinpin Lin, ^a   Han Chang, ^a   Tsai, Wen Tin ^b   wu, Meng Hsiang ^b   Liao, Yung Shen ^b   Chen, Jung ta ^c   su, Jang Ming ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

adenocarcinoma; Aryl hydrocarbon receptor; lung carcinoma; overexpression

Indexed keywords

AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; MESSENGER RNA; POLYCYCLIC AROMATIC COMPOUND;

ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 12244268606     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230390173824     Document Type: Article

References (36)

1. Anttila S., Hietanen E., Vainio H., Camus A-M., Gelboin HV, Park SS, Heikkila L., Karjalainen A., Bartsch H. (1991). Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P4501A in lung cancer patients. Int J Cancer 47: 681-685.
2. Barbone F., Bovenzi M., Cavallieri F., Stanta G. (1997). Cigarette smoking and histologic type of lung cancer in men. Chest I 12: 1474-1479.
3. Boffetta P., Jourenkova N., Gustavsson P. (1997). Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8: 444-472.
4. Chang KW, Lee H., Wang HJ, Chen SY, Lin P. (1999). Differential response to benzo[a]pyrene in human lung adenocarcinoma cell lines: The absence of aryl hydrocarbon receptor activation. Life Sci 65: 1339-1349.
5. Department of Health, the Executive Yuan (1998). Republic of China: General Health Statistics. Health and Vital Statistics, Republic of China. ROC Press, Taipei, pp 82-89.
6. De Vries A., Dolle ME, Broekhof JL, Muller JJ, Kroese ED, Kreijl CF, Capel PJ, Vijg J., Steeg H. (1997). Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: Correlation with tumour development. Carcinogenesis 18: 2327-2332.
7. Fernandez-Salguero PM, Hilbert DM, Rudikoff S., Ward JM, Gonzalez FJ (1996). Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducedtoxicity. ToxicolApplPharmacol 140: 173-179.
8. Gazdar AF, Minna JD (1997). Cigarettes, sex, and lung adenocarcinoma. J Natl Cancer Inst 89: 1563-1565.
9. Hayashi S-I., Watanabe J., Nakachi K., Eguchi H., Gotoh O., Kawajiri K. (1994). Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15: 801-806.
10. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR (1996). 17β estradiol hydroxylation catalyzed by human cytochrome P4501B1. Proc Natl Acad Sci USA 93: 9776-9781.
11. Hsu JW, Hsu SL, Chu JJ, Liu MC, Chiang CD (1997). Increased NM23:MTS1 ratio inversely correlated with metastasis behaviour in human lung squamous cell carcinoma. Anticancer Res 17: 407-411.
12. Iwagawa M., Maeda T., Izumi K., Otsuka H., Nishifuji K., Ohnishi Y., Aoki S. (1989). Comparative dose-response study on the pulmonary carcinogenicity of 1,6-dinitropyrene and benzo[a]pyrene in F344 rats. Carcinogenesis 10: 1285-1290.
13. Kashani M., Steiner G., Haitel A., Schaufler K., Thalhammer T., Amann G., Kramer G., Marberger M., Scholler A. (1998). Expression of the aryl hydrocarbon receptor (AhR) and the aryl hydrocarbon receptor nuclear translocator (ARNT) in fetal, benign, hyperplastic and malignant prostate. Prostate 37: 98-108.
14. Kellermann G., Shaw CR, Luyten-Kellermann M. (1973). Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Eng J Med 263: 131-133.
15. Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Barnard SD, Hummel RA, Humiston CG (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46: 279-303.
16. Kogevinas M. (2000). Studies of cancer in humans. Food Addit Contamin 17: 317-324.
17. Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL (1982). Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. Cancer Res 42: 5030-5037.
18. Kress S., Greenlee WF (1997). Cell-specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res 57: 1264-1269.
19. Lee TC, Ho IC (1994). Expression of heme oxygenase in arsenic-resistant human lung adenocarcinoma cells. Cancer Res 54: 1660-1664.
20. Lin P., Wang SL, Wang HJ, Chen KW, Lee HS, Tsai KJ, Chen CY, Lee H. (2000). Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. J Cancer 82: 852-857.
21. Murray GI, Taylor MC, McFayden MCE, McKay JA, Greenlee WF, Burke MD, Melvin WT (1997). Tumor-specific expression of cytochrome P4501B1. Cancer Res 57: 3026-3031.
22. Osann KE (1998). Epidemiology of lung cancer. Current Opin Pulmon Med 4: 198-204.
23. Pisani P., Parkin DM, Bray F., Ferlay J. (1999). Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18029.
24. Prasad R., Prasad N., Harrell JE, Thornby J., Liem JH, Hudgins PT, Tsuang J. (1979). Aryl hydrocarbon hydroxylase inducibility and lymphoblast formation in lung cancer patients. Int J Cancer 23: 316-320.
25. Rowlands JC, Gustafsson JK (1997). Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol 27: 109-134.
26. Saarikoski S., Husgafvel-Pursiainen K., Hirvonen A., Vainio H., Gonzalez FJ, Anttila S. (1998). Localization of CYP1A1 mRNA in human lung by in situ hybridization: Comparison with immunohistochmical findings. Int J Cancer 77: 33-39.
27. Shimada T., Hayes CL, Yamazaki H., Amin S., Hecht SS, Guengerich FP (1996). Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Res 56: 2979-2984.
28. Shimada T., Yun CH, Yamazaki H., Gautier JC, Beaune PH, Guengerich FP (1992). Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 41: 856-864.
29. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., Fujii-Kuriyama Y., Ishikawa T. (2000). Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 97: 779-782.
30. Spivack SD, Hurteau GJ, Reilly AA, Aldous KM, Ding X., Kaminsky LS (2001). CYP1B1 expression in human lung. Drug Metab Dispos 29: 916-922.
31. Stucker I., Jacquet M., De Waziers I., Cenee S., Beaune PH, Kremers P., Hemon D. (2000). Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French population. Pharmacogenentics 10: 617-627.
32. Tritscher AM, Mahler J., Portier CJ, Lucier GW, Walker NJ (2000). Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Pathol 28: 761-769.
33. Trombino AF, Near RI, Matulka RA, Yang S., Hafer LJ, Toselli PA, Kim DW, Rogers AE, Sonenshein GE, Sherr DH (2000). Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res Treat 63: 117-131.
34. Wang HW, Chen TL, Yang PC, Ueng TH (2001). Induction of cytochromes P450 1A1 and 1B1 by emodin in human lung adenocarcinoma cell line CL5. Drug Metab Dispos 29: 1229-1235.
35. Ward E., Paigen B., Steenland K., Vincent R., Minowada J., Gurtoo HL, Sartori P., Havens MB (1978). Aryl hydrocarbon hydroxylase in persons with lung or laryngeal cancer. Int J Cancer 22: 384-389.
36. Whitlock Jr JP (1999). Induction of cytochrome P4501A1. Ann Rev Pharmacol Toxicol 39: 103-125.